Study number 8548-638
Dates
Sep 08 2025-Nov 04 2025
Location
Madison, Wisconsin
Age
18-55
Gender
Male and Female
Smoker
No
Compensation
$8,378
Group
B2a
The investigational drug in this research is being developed for the potential treatment of plycythemia vera, which, is a certain kind of cancer where the body produces too many red blood cells.
Women Eligibility Criteria
Body Mass Index (BMI)
Smoking Criteria
Medication Restrictions
Screening Procedures
B2a:
Check-in: Sep 8
Check-out: Sep 11
Check-in: Sep 15
Check-out: Sep 16
Check-in: Oct 6
Check-out: Oct 7
Check-in: Nov 3
Check-out: Nov 4
Follow-up Visits: Sep 23, Oct 21